Cite
MLA Citation
Rahima Jamal et al.. “Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma.” Journal for immunotherapy of cancer, vol. 4, no. 1, 2016, p. . http://access.bl.uk/ark:/81055/vdc_100144509749.0x000006